Hochstufung der COVID-19-Risikobewertung durch das RKI im März 2020

This written question concerns the decision by the Robert Koch Institute (RKI) to upgrade the COVID-19 risk level in March 2020. It seeks to clarify the reasoning and evidence used by health authorities to justify the change in risk assessment during the early stages of the pandemic. The procedure primarily affects public health policy and government accountability. It examines the decision-making process of national health experts and its impact on the subsequent lockdown measures implemented in Germany.